IP Library › Granted Patent US 10,668,260
Granted Patent B2
US 10,668,260 · App. 14/774,385 · Granted Jun 2, 2020

Microneedle patch

Inventors: Yoshihiro Omachi (Osaka, JP); Yasuhiro Hiraishi (Osaka, JP); Masami Kusaka (Osaka, JP); Shigehiro Asano (Osaka, JP); Masao Nagao (Yamaguchi, JP)
Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
A61M37/0015A61K9/0021A61K9/7092B29C45/0053B29C45/1615A61M2037/0023A61M2037/0046A61M2037/0053B29K2101/12B29K2995/0056B29L2009/00B29L2031/753
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,668,260
App. No.
14/774,385
Granted
Jun 2, 2020
Kind
B2
Abstract

The present invention provides a microneedle patch which can solve the problem that microneedle production is difficult and requires high accuracy, the problem that time and mental burdens on a health professional and a patient are large, and the problem caused by compounding a plurality of drugs. The microneedle patch comprises a large number of drug-carrying microprojections 4 erected on one support sheet, each microprojection 4 having a drug layer 5 soluble in vivo at its top part and having an intermediate layer 6 under the drug layer 5 , the intermediate layer 6 containing a polymeric substance for adhesion of the drug layer 5 to the support sheet, the drug layer 5 at the top part of the microprojection 4 containing a single drug, the microprojections 4 holding difference types of drugs being arranged together on the support sheet 2.

Claims (31)

1. A microneedle patch comprising:

a distribution of drug-carrying microprojections in a density of about dozens to hundreds per cm square soluble in vivo erected on one support sheet,

wherein each microprojection comprises a single drug layer soluble in vivo at a top part of each said microprojection, the single drug layer at the top part comprises a single drug,

the one support sheet is provided under the distribution of drug-carrying microprojections, and

the distribution of drug-carrying microprojections holds a plurality of types of drugs and are arranged together on the one support sheet.

2. The microneedle patch according to claim 1 , wherein each said microprojection further comprises an intermediate layer comprising a polymeric substance for adhesion of the drug layer to the one support sheet formed under the drug layer.

3. The microneedle patch according to claim 1 , wherein the drug concentration is varied among the drug layer.

4. The microneedle patch according to claim 1 , wherein each drug is arranged in a different pattern and distribution density in the microneedle patch to vary an intake amount of each drug.

5. The microneedle patch according to claim 1 , wherein a drug content of one microprojection is 25 ng or more.

6. The microneedle patch according to claim 1 , wherein the plurality of types of drugs is 3 to 6 types of vaccines.

7. The microneedle patch according to claim 1 , wherein

the drug layer comprises a peripheral part and a central part, and

a concentration of the drug is low in the peripheral part and high in the central part, or

the concentration of the drug is high in the peripheral part and low in the central part.

8. A method for producing a microneedle patch, comprising:

producing a resin molding die having recessions for forming microprojections using a matrix having a distribution of microprojections in a density of about dozens to hundreds per cm square erected thereon,

injecting drugs into the recessions of the resin molding die and forming drug layers soluble in vivo at top parts of the recessions by an air press,

applying the drug layers onto one support sheet, and

removing a microneedle patch having the distribution of microprojections formed on the one support sheet from the resin molding die,

to obtain a microneedle patch wherein each microprojection of the distribution of microprojections contains a single drug layer soluble in vivo at a top part of each said microprojection, the single drug layer at the top part comprises a single drug, and the distribution of microprojections holds a plurality of types of drugs and are arranged together on the one support sheet.

9. The method according to claim 8 , further comprising:

injecting a resin adhesive onto the drug layers in the recessions to form resin layers for adhesion.

10. A method for producing a microneedle patch, comprising:

producing a resin molding die having recessions for forming microprojections using a matrix having a distribution of microprojections in a density of about dozens to hundreds per cm square erected thereon;

injecting one type of drug into selected recessions of the resin molding die to form drug layers soluble in vivo at top parts of the recessions by an air press, injecting another type of drug into other selected recessions of the resin molding die and forming drug layers soluble in vivo at the top parts of the recessions by an air press, and

repeating these injection steps and air press steps a plurality of times to form drug layers for a plurality of types of drugs contained in separate recessions at the top parts of the recessions;

applying the drug layers onto one support sheet; and

removing a microneedle patch having the distribution of microprojections formed on the one support sheet from the resin molding die,

to obtain a microneedle patch wherein each microprojection of the distribution of microprojections contains a drug layer soluble in vivo at a top part of each said microprojection, and the drug layer at the top part comprises a single drug.

11. The method according to claim 10 , further comprising:

injecting a resin adhesive onto the drug layers in the recessions to form resin layers for adhesion.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 9, 2015
From: OMACHI, YOSHIHIRO; HIRAISHI, YASUHIRO; KUSAKA, MASAMI; ASANO, SHIGEHIRO; NAGAO, MASAO
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 036990/0407 →
Priority Claims (1)
JP 2013-049493 · Mar 12, 2013 · national
Continuity (1)
Related Publication 20160015952A1 · Jan 21, 2016
Cited By (3)
US 12,186,515 US 12,708,750 US 12,714,838